Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Slavin

Showing results (401-410 of 436) with videos related to

Pageof 44
Sort By:
AIDS and Behavior|November 30, 2014
Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral TherapyC E Newman, J de Wit, A Persson, et al.
Transplantation|April 15, 1996
Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patientsR Or, A Nagler, O Shpilberg, et al.
Transplantation Proceedings|March 1, 1981
Total lymphoid irradiation and kidney transplantation: a clinical experienceJ S Najarian, D E Sutherland, R M Ferguson, et al.
Leukemia & Lymphoma|June 1, 1999
Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphomaG Varadi, R Or, J Kapelushnik, et al.
Bone Marrow Transplantation|July 6, 2004
Low transplant-related mortality with allogeneic stem cell transplantation in elderly patientsM Y Shapira, I B Resnick, M Bitan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998
Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantationR Or, A Ackerstein, A Nagler, et al.
Bone Marrow Transplantation|September 4, 2003
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantationM Y Shapira, R Or, I B Resnick, et al.
Presse Medicale (Paris, France : 1983)|January 30, 1993
[Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas]N C Gorin, B Coiffier, M Hayat, et al.
Bone Marrow Transplantation|November 22, 2005
Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndromeN Kröger, R Brand, A van Biezen, et al.
Immunological Reviews|January 1, 1979
Allograft tolerance after total lymphoid irradiation (TLI)S Strober, S Slavin, M Gottlieb, et al.
Pageof 44

Showing results (401-410 of 436) with videos related to

Sort By:
Pageof 44
AIDS and Behavior|November 30, 2014
Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral TherapyC E Newman, J de Wit, A Persson, et al.
Transplantation|April 15, 1996
Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patientsR Or, A Nagler, O Shpilberg, et al.
Transplantation Proceedings|March 1, 1981
Total lymphoid irradiation and kidney transplantation: a clinical experienceJ S Najarian, D E Sutherland, R M Ferguson, et al.
Leukemia & Lymphoma|June 1, 1999
Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphomaG Varadi, R Or, J Kapelushnik, et al.
Bone Marrow Transplantation|July 6, 2004
Low transplant-related mortality with allogeneic stem cell transplantation in elderly patientsM Y Shapira, I B Resnick, M Bitan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998
Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantationR Or, A Ackerstein, A Nagler, et al.
Bone Marrow Transplantation|September 4, 2003
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantationM Y Shapira, R Or, I B Resnick, et al.
Presse Medicale (Paris, France : 1983)|January 30, 1993
[Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas]N C Gorin, B Coiffier, M Hayat, et al.
Bone Marrow Transplantation|November 22, 2005
Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndromeN Kröger, R Brand, A van Biezen, et al.
Immunological Reviews|January 1, 1979
Allograft tolerance after total lymphoid irradiation (TLI)S Strober, S Slavin, M Gottlieb, et al.
Pageof 44